Imprint

MetrioPharm AG

Bleicherweg 45
8002 Zurich
Switzerland

Phone: +41 (44) 515 21 97
Fax: +41 (44) 201 74 75

Commercial Register number: CH-020/3/026/312-9
Stock Exchange of Frankfurt: WKN A0YD9Q / ISIN CH0107076744
VAT Reg. No. according to §27a UStG: DE257956011

Research & Development Center
Mailing address:

MetrioPharm AG
Neuendorfstraße 20 b
16761 Hennigsdorf
Germany

President of the administrative board: Dr. Wolfgang Brysch
Chief Executive Officer: Ekkehard Brysch

Phone: +49 3302 202 34 02

Web: www.metriopharm.com
Email: info[at]metriopharm.com

Disclaimer

MetrioPharm AG is responsible for its own contents of this website according to the general laws. However, MetrioPharm AG assumes no liability for the correctness, completeness and actuality of the information of the website. Furthermore, MetrioPharm AG accepts no liability for the damages which originate from the direct or indirect use of the contents of this website. The contents of this website can be altered, changed, and removed at any time without advance notice.

The contents of this website must be distinguished from the contents of the links we provide. They serve solely the purpose of providing the continuing information. Before linking the references were checked for possible violations of the law. Any further checking of the external contents is beyond our resources. The contents of such third-party sites are the sole responsibility of the respective owner who can change the information offered on their website at any time without prior knowledge of MetrioPharm AG. As soon as MetrioPharm AG becomes aware of infringements the link will be deleted immediately.

The provided contents serve for your information only. They do not comprise an investment recommendation. Furthermore, it should not be considered as a consultation for legal or tax advice.

The contents published on this website are protected by copyright. The use of the contents is permitted solely for personal, private and non-commercial purposes. Any use which is not permitted by the copyright needs the prior written approval of the beneficiary, normally MetrioPharm AG. MetrioPharm will delete works which violate copyright laws of third parties immediately, as soon as the infringement becomes known to MetrioPharm.

Data protection

The use of this website is possible without input of your personal data. Your personal data are only collected if you sign up for the MetrioPharm AG newsletter. MetrioPharm AG will keep these data confidentially and not transmit these data to third parties.